Compass Therapeutics Grants New Employee Stock Options for 200,000 Shares
Compass Therapeutics granted a new employee non-qualified stock options to purchase 200,000 common shares under its 2025 Inducement Plan. The options have a $0.86 per-share exercise price and a 10-year term. Vesting spans four years, with 25% vesting on the grant’s first anniversary. The remaining 75% vests in 36 subst